{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:19:06Z","timestamp":1777551546153,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CORPF1N0092"],"award-info":[{"award-number":["CORPF1N0092"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPF1N0031"],"award-info":[{"award-number":["CMRPF1N0031"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2320-B-255-009-MY3"],"award-info":[{"award-number":["NSTC 112-2320-B-255-009-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002836","name":"Chang Gung University","doi-asserted-by":"publisher","award":["ZRRPF3N0091"],"award-info":[{"award-number":["ZRRPF3N0091"]}],"id":[{"id":"10.13039\/501100002836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Linkou Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejphar.2026.178607","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:21:06Z","timestamp":1769559666000},"page":"178607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Magnolol suppresses TKI-resistant EGFR-mutant lung cancer by inhibiting EGFR and AXL-cMyc"],"prefix":"10.1016","volume":"1016","author":[{"given":"Chin-Chuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann-Lii","family":"Leu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh-Wen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5496-8573","authenticated-orcid":false,"given":"Yu-De","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4995-297X","authenticated-orcid":false,"given":"Chi-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178607_bib1","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/ng.3990","article-title":"Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers","volume":"49","author":"Blakely","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2026.178607_bib2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41419-018-0575-0","article-title":"Corylin increases the sensitivity of hepatocellular carcinoma cells to chemotherapy through long noncoding RNA RAD51-AS1-mediated inhibition of DNA repair","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2026.178607_bib3","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm.3388","article-title":"The quest to overcome resistance to EGFR-targeted therapies in cancer","volume":"19","author":"Chong","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2026.178607_bib4","doi-asserted-by":"crossref","first-page":"7241","DOI":"10.7150\/thno.97593","article-title":"ZNF131-BACH1 transcriptionally accelerates RAD51-dependent homologous recombination repair and therapy-resistance of non-small-lung cancer cells by preventing their degradation from CUL3","volume":"14","author":"Fan","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2026.178607_bib5","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41401-024-01237-4","article-title":"Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer","volume":"45","author":"Han","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2026.178607_bib6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3390\/biom11091271","article-title":"Growth suppression in lung cancer cells harboring EGFR-C797S mutation by quercetin","volume":"11","author":"Huang","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2026.178607_bib7","doi-asserted-by":"crossref","first-page":"20558","DOI":"10.1074\/jbc.M111.240796","article-title":"Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells","volume":"286","author":"Huang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.178607_bib8","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.21873\/anticanres.15873","article-title":"Magnolol induces apoptosis through Extrinsic\/intrinsic pathways and attenuates NF-\u03baB\/STAT3 signaling in non-small-cell lung cancer cells","volume":"42","author":"Lee","year":"2022","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2026.178607_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pharmthera.2011.01.010","article-title":"Therapeutic applications of compounds in the Magnolia family","volume":"130","author":"Lee","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.178607_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106668","article-title":"Anlotinib combined with osimertinib reverses acquired osimertinib resistance in NSCLC by targeting the c-MET\/MYC\/AXL axis","volume":"188","author":"Lei","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.178607_bib11","doi-asserted-by":"crossref","first-page":"16307","DOI":"10.1021\/acsomega.0c02183","article-title":"Molecular dynamics analysis of binding sites of epidermal growth factor receptor kinase inhibitors","volume":"5","author":"Li","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejphar.2026.178607_bib12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41401-020-00577-1","article-title":"Targeting DNA-PK overcomes acquired resistance to third-generation EGFR-TKI osimertinib in non-small-cell lung cancer","volume":"42","author":"Liang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2026.178607_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.phrs.2016.05.028","article-title":"Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-Induced apoptosis in non-small cell lung cancer","volume":"111","author":"Liu","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.178607_bib14","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/ijc.32487","article-title":"Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2\/JUN\/AXL signaling in lung cancer","volume":"145","author":"Liu","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2026.178607_bib15","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1158\/2159-8290.CD-22-0111","article-title":"AXL and error-prone DNA replication confer drug resistance and offer strategies to treat EGFR-mutant lung cancer","volume":"12","author":"Noronha","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejphar.2026.178607_bib16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12272-011-0413-8","article-title":"Anticancer potential of magnolol for lung cancer treatment","volume":"34","author":"Seo","year":"2011","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejphar.2026.178607_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41467-018-08074-0","article-title":"AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells","volume":"10","author":"Taniguchi","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178607_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nm.3854","article-title":"Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M","volume":"21","author":"Thress","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2026.178607_bib19","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s12272-013-0232-1","article-title":"Magnolol induces apoptosis via caspase-independent pathways in non-small cell lung cancer cells","volume":"37","author":"Tsai","year":"2014","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejphar.2026.178607_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14768","article-title":"Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer","volume":"8","author":"Uchibori","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178607_bib21","article-title":"Curcumin-Mediated HDAC inhibition suppresses the DNA damage response and contributes to increased DNA damage sensitivity","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178607_bib22","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/ptr.7432","article-title":"Psorachromene induces apoptosis and suppresses tumor growth in NSCLC cells harboring EGFR L858R\/T790M\/C797S","volume":"36","author":"Wang","year":"2022","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2026.178607_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41389-020-0225-0","article-title":"Profiling of subcellular EGFR interactome reveals hnRNP A3 modulates nuclear EGFR localization","volume":"9","author":"Wang","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ejphar.2026.178607_bib24","article-title":"Integrated omics analysis of non-small-cell lung cancer cells harboring the EGFR C797S mutation reveals the potential of AXL as a novel therapeutic target in TKI-Resistant lung cancer","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2026.178607_bib25","article-title":"Magnolol as a potential anticancer agent: a proposed mechanistic Insight","volume":"27","author":"Wang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.178607_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev-med-051718-013524","article-title":"Precision management of advanced non-small cell lung cancer","volume":"71","author":"Yang","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2026.178607_bib27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41392-020-00251-2","article-title":"Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth","volume":"5","author":"Yao","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.178607_bib28","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/1878-0261.12645","article-title":"Overcoming acquired resistance of EGFR-mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol","volume":"14","author":"Zang","year":"2020","journal-title":"Mol. Oncol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:54:56Z","timestamp":1777398896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926000890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":28,"alternative-id":["S0014299926000890"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178607","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnolol suppresses TKI-resistant EGFR-mutant lung cancer by inhibiting EGFR and AXL-cMyc","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178607"}}